Shannon Green, APRN
Nurse Practitioner · Greenville, SCNPI 1992772073
Payments from drug & device makers
Across 105 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$281
- Dexcom, Inc.$266
- AbbVie$203
- Novo Nordisk$164
- GSK$128
- Bayer$110
- plus $662 from 21 others
What the payments were for
- Food & beverage$1,815100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 13 | $281 |
| Dexcom, Inc. | 14 | $266 |
| AbbVie | 16 | $203 |
| Novo Nordisk | 10 | $164 |
| GSK | 7 | $128 |
| Bayer | 8 | $110 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $99 |
| Incyte Corporation | 1 | $77 |
| AstraZeneca | 5 | $66 |
| Esperion Therapeutics, Inc. | 4 | $58 |
| Amgen | 3 | $55 |
| Boston Scientific | 2 | $37 |
| Lilly USA, LLC | 2 | $30 |
| Johnson & Johnson | 1 | $24 |
| Antares Pharma, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Novartis | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Exact Sciences | 1 | $16 |
| Shionogi Inc | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Pfizer | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Abbott | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$1,815 in reported general payments places this provider in the 85th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 88 | $94,625 |
| JanuviaSitagliptin Phosphate | 56 | $42,817 |
| JardianceEmpagliflozin | 48 | $40,230 |
| MounjaroTirzepatide | 26 | $27,498 |
| XareltoRivaroxaban | 15 | $22,029 |
| TradjentaLinagliptin | 18 | $19,855 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $14,639 |
| Repatha SureclickEvolocumab | 17 | $13,851 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $10,759 |
| Atorvastatin Calcium | 398 | $4,218 |
| SynthroidLevothyroxine Sodium | 41 | $3,308 |
| Rosuvastatin Calcium | 204 | $2,932 |
| Omeprazole | 206 | $2,827 |
| Levothyroxine Sodium | 280 | $2,733 |
| Potassium Chloride | 101 | $2,149 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $94,62588 claims |
| Boehringer IngelheimJardiance, Tradjenta | $281 | $60,08566 claims |
| Lilly USA, LLCMounjaro | $30 | $27,49826 claims |
| Johnson & JohnsonXarelto | $24 | $22,02915 claims |
| AbbVieSynthroid | $203 | $3,30841 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $18 | $2,733280 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Greenville
- David WiltGreenville$90K
- Mae BurtonGreenville$21K
- Deborah MooreGreenville$12K
- Cindy LoebGreenville$9K
- Ashley BurrissGreenville$8K
- Kristina AldrichGreenville$7K
- Jenna DavisColumbia$202K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.